YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
Option Care (OPCH) shares ended the last trading session 32.7% higher at $31. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 3.5% loss over the…
DaVita HealthCare (DVA) closed the most recent trading day at $178.69, moving +1.33% from the previous trading session. The stock exceeded the S&P 500, which registered a gain of 0.73% for the day. Meanwhile, the Dow gained 0.49%, and the…
3 Cash-Producing Stocks with Open Questions A company that generates cash isn't automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. Not all companies are created equal, and…
DaVita has delivered a strong 87.2% share price gain over the past three years, which naturally raises a question for anyone looking at the stock today. Is the current valuation still grounded in the earnings power of the dialysis provider…
DaVita HealthCare (DVA) ended the recent trading session at $174.67, demonstrating a -4.62% change from the preceding day's closing price. The stock trailed the S&P 500, which registered a daily loss of 0.03%. Meanwhile, the Dow experience…
1 Profitable Stock with Competitive Advantages and 2 That Underwhelm Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn't mean it w…
NEW YORK, Sept. 21, 2026 /PRNewswire/ -- AllianceBernstein Global High Income Fund, Inc. [NYSE: AWF] (the "Fund") today released its monthly portfolio update as of August 31, 2026. AllianceBernstein Global High Income Fund, Inc. Top 10 Fix…
Key Points Interested in DaVita Inc.? Here are five stocks we like better. DaVita, Franklin Resources, and Archer Daniels Midland have each gained more than 30% year to date without relying on AI-driven market momentum. DaVita's dialysis b…
Q2 Earnings Roundup: Encompass Health (NYSE:EHC) And The Rest Of The Outpatient & Specialty Care Segment As the craze of earnings season draws to a close, here's a look back at some of the most exciting (and some less so) results from Q2.…
DaVita HealthCare (DVA) ended the recent trading session at $193.86, demonstrating a +1.55% change from the preceding day's closing price. The stock's performance was ahead of the S&P 500's daily loss of 0.45%. Meanwhile, the Dow lost 1.21…
[Health Care Medical Stock Market Industry Sector Wall Street Buildings 3d Illustration] iQoncept/iStock via Getty Images Healthcare stocks continue to attract investor attention as managed care providers, pharmaceutical companies, biotech…
Paving Career Paths to Economic Mobility NORTHAMPTON, MA / ACCESS Newswire / September 14, 2026 / Sustainable career growth is about unlocking lasting economic mobility and new opportunities to learn and grow as an individual. In an evolvi…
NORTHAMPTON, MA / ACCESS Newswire / September 10, 2026 / 2025 marked a proud moment for DaVita as we met our goal to power 100% of our global operations with renewable energy. We achieved this by securing multiple virtual power purchase ag…
DaVita Inc. DVA has been gaining from strong execution across its Integrated Kidney Care (IKC) platform, improving treatment volumes and investments in technology and clinical innovation. The optimism is led by solid first-quarter 2026 res…
3 Reasons to Sell DVA and 1 Stock to Buy Instead DaVita's 20.6% return over the past six months has outpaced the S&P 500 by 7%, and its stock price has climbed to $183.98 per share. This performance may have investors wondering how to appr…
NORTHAMPTON, MA / ACCESS Newswire / September 8, 2026 / DaVita's care network reaches people in every corner of the U.S. as well as 14 countries around the world. In every community the comprehensive kidney care provider touches, DaVita ex…
Wall Street's major market averages finished lower on Friday after traders and investors digested the latest jobs data, which came in stronger than forecasted. The blue-chip Dow ended 0.5% lower, the benchmark S&P 500 slipped 0.3%, and the…
[Health Care Medical Concept] ogichobanov/iStock via Getty Images The healthcare sector (XLV [https://seekingalpha.com/symbol/XLV]) gained 4.91% in August, outperforming the broader S&P 500 (SPY [https://seekingalpha.com/symbol/SPY]), whic…
NORTHAMPTON, MA / ACCESS Newswire / September 4, 2026 / At DaVita, doing the right thing and conducting business activities with the highest standards of ethics is foundational to our culture. We are firmly committed to compliance with our…
It has been about a month since the last earnings report for Encompass Health (EHC). Shares have lost about 1.8% in that time frame, underperforming the S&P 500. Will the recent negative trend continue leading up to its next earnings relea…
3 of Wall Street's Favorite Stocks We Find Risky Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it's worth remembering that analysts rarely issue se…
DaVita (DVA) is back in focus after two meaningful developments. The company expanded its value based care partnership with Humana for chronic kidney disease patients and agreed to a US$15 million settlement related to a prior data breach.…
Fresenius Medical Care AG FMS is accelerating the U.S. rollout of its 5008X CAREsystem as it pushes high-volume hemodiafiltration, or HVHDF, into more clinics. The deployment adds a technology-led growth avenue across both services and pro…
It has been about a month since the last earnings report for DaVita HealthCare (DVA). Shares have lost about 4.9% in that time frame, underperforming the S&P 500. Will the recent negative trend continue leading up to its next earnings rele…
Investors in DaVita Inc. DVA need to pay close attention to the stock based on moves in the options market lately. That is because the Sep 18, 2026 $350 Put had some of the highest implied volatility of all equity options today. What is Im…
1 Value Stock to Target This Week and 2 We Find Risky Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they're out of favor. The key risk, however, is that t…
1 Value Stock with Impressive Fundamentals and 2 Facing Headwinds The low valuation multiples for value stocks provide a margin of safety that growth stocks rarely offer. However, the challenge lies in determining whether these cheap asset…
Q2 Earnings Highs And Lows: The Ensign Group (NASDAQ:ENSG) Vs The Rest Of The Healthcare Providers & Services Stocks Earnings results often indicate what direction a company will take in the months ahead. With Q2 behind us, let's have a lo…
For Immediate Release Chicago, IL – August 31, 2026 – Today, Zacks Equity Research discusses DaVita Inc. DVA, LifeStance Health Group, Inc. LFST, Option Care Health, Inc. OPCH and Aveanna Healthcare Holdings Inc. AVAH. Industry: Outpatient…
The Zacks Medical – Outpatient and Home Healthcare industry is undergoing a rapid transition toward digital modes of care delivery. Demand for telemedicine platforms and artificial intelligence (AI)-powered medical solutions has increased…
CVS Health CVS is building strong momentum in its Pharmacy and Consumer Wellness segment. The segment's broad footprint, as of June 30, 2026, includes nearly 9,000 retail locations, online retail pharmacy websites, retail specialty pharmac…
DaVita DVA recently announced a new value-based care agreement with Humana to provide comprehensive, coordinated care to more than 10,000 Humana Medicare Advantage members with chronic kidney disease (CKD) stages 3B–5. The program, which b…
SHANGHAI, Aug. 26, 2026 /PRNewswire/ -- Alebund Pharmaceuticals (Jiangsu) Limited ("Alebund" or the "Company"; stock code: 09637.HK), a renal-focused biopharmaceutical company, today announced its unaudited consolidated interim results for…
SHANGHAI, Aug. 26, 2026 /PRNewswire/ -- Alebund Pharmaceuticals (Jiangsu) Limited ("Alebund" or the "Company"; stock code: 09637.HK), a renal-focused biopharmaceutical company, today announced its unaudited consolidated interim results for…
Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. Humana stock has delivered a strong 46.2% return year to date, yet the valuation checks paint a m…
More than 10,000 members will get added support aimed at delaying or preventing dialysis and reducing hospitalizations DENVER, Aug. 25, 2026 /PRNewswire/ -- DaVita today announced a new value-based care agreement to deliver comprehensive,…